Myeloma Momentum Webinar Gulf series

Dr. Ahmad Al Huraiji

🇰🇼

Chairperson · Consultant Hematologist
Kuwait Cancer Control Center · Kuwait

Biography

Ahmad Alhuraiji is a hemato-oncologist consultant working in the department of hematology at Kuwait Cancer Control Centre. His main focus of interest is the field of leukemia, myeloproliferative neoplasms, myelodysplastic syndrome and plasma cell disorders. He is involved in education and training of residents of the Kuwaiti hematology residency program and helped establish the adult hematology clinical fellowship program in 2020.

Prof. María-Victoria Mateos, MD, PhD

🇪🇸

International Speaker · Consultant Physician, Hematology & Associate Professor of Medicine
Director, Myeloma Program & Clinical Trials Unit · University Hospital of Salamanca · Spain

Biography

Maria-Victoria Mateos received her medical degree from the University of Valladolid and completed her residency and PhD at the University Hospital of Salamanca. She coordinates the clinical trials unit and directs the Myeloma Program. Dr Mateos has served on the EHA Scientific Program Committee, the ASH Plasma Cell Diseases committee, and is associate editor of Annals of Haematology. She has conducted numerous clinical trials and published over 150 peer-reviewed papers.

Dr. Hani Osman

🇦🇪

Moderator · Consultant Hematologist
Tawam Hospital · UAE

Biography

Dr. Hani Yousif Osman specializes in hematological malignancies such as acute leukemia, lymphomas, multiple myeloma, and myeloproliferative disorders. He also manages bleeding disorders and benign hematological conditions, providing advanced personalized care at Tawam Hospital.

Dr. Emmanouil (Manos) Nikolousis

🇦🇪

Speaker · Director, Cancer Center; Consultant Hematologist & BMT
American Hospital Dubai · UAE

Biography

Dr. Nikolousis is UK board-certified in Clinical Hematology and Bone Marrow Transplant with over 18 years of experience. He trained in the West Midlands and served as Clinical Director at Heartlands Hospital, University Hospitals Birmingham (UK). He has also worked in Greece and Cyprus and was Associate Professor of Hematology and Chair of the Medical School at the European University of Cyprus. Interests include benign/malignant hematology, transplantation, and cellular therapies.

Dr. Mohammad Ebraheem

🇰🇼

Speaker · Consultant Hematologist
Kuwait Cancer Control Center · Kuwait

Biography

Dr. Mohammad Soliman Ebraheem is a malignant hematologist with a special interest in plasma cell neoplasms. He trained at McMaster University (Canada), followed by an advanced fellowship in multiple myeloma, amyloidosis, and dysproteinemias at Mayo Clinic Rochester. He also holds a Master’s in Health Research Methodology from McMaster University.

Dr. Mohan Ram

🇰🇼

Speaker · Hematologist
Kuwait Cancer Control Center · Kuwait

Biography

Dr. Mohan Ram is a practicing hematologist at the Kuwait Cancer Control Center with a focus on multiple myeloma and related plasma cell disorders. (Detailed biography forthcoming.)

Dr. Hesham El Sabah

🇶🇦

Panelist · Consultant Hematologist
Hamad Medical Corporation · Qatar

Biography

Dr. Hesham El-Sabah graduated from College of Medicine, Bagdad University (2000). He completed Internal Medicine training and received the Arab Board in 2008, followed by a Hematology fellowship at NCCCR, Hamad Medical Corporation, Doha. He is currently a Consultant Hematologist at NCCCR and has published in peer-reviewed journals.

Introduction & Welcoming

Addressing unmet needs with a new mechanism of action:Role and place of XPO1 inhibition

Clinical Case UAE Market

2 Clinical Cases Kuwait Market

Panel Discussion: RRMM from Theory to Practice

Closing Remarks

Dr. Ahmad Al Huraiji

Prof. María-Victoria Mateos, MD, PhD

Dr. Hani Osman

Dr. Emmanouil (Manos) Nikolousis

Dr. Mohammad Ebraheem

Dr. Mohan Ram

Dr. Hesham El Sabah